In CPS1 deficiency treatment can prevent hyperammonemic crisis and adverse neurological outcomes, while in primary forms of coenzyme Q10 deficiency treatment can prevent the progression of both steroid-resistant nephrotic syndrome and encephalopathy, hence the critical importance of a prompt diagnosis. This evidence concerns the gene CPS1 and nephrotic syndrome.